Incannex Healthcare (IXHL) News Today → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free IXHL Stock Alerts $2.30 +0.04 (+1.77%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIncannex Healthcare (NASDAQ:IXHL) Shares Down 1.7% americanbankingnews.com - April 19 at 3:30 AMPsyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influencemsn.com - March 29 at 2:43 PMShort Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Grows By 113.1%marketbeat.com - March 28 at 8:23 PMIncannex Healthcare Inc IXHLmorningstar.com - March 24 at 3:59 AMPsychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Coloradomsn.com - March 22 at 4:54 PMmarketbeat.com - March 19 at 4:04 PMIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 57.3% in Februarymarketbeat.com - March 3 at 6:44 PMIncannex's Phase 2 Psi-GAD1 Trial Of Psilocybin Meets Primary Endpoint; Stock Surges 39%markets.businessinsider.com - February 28 at 3:13 PMNovavax, Applied Therapeutics, Incannex among healthcare moversmsn.com - February 28 at 10:13 AMIncannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorderfinance.yahoo.com - February 28 at 10:13 AMmarketbeat.com - February 28 at 9:47 AMmarketbeat.com - February 28 at 9:43 AMmarketbeat.com - February 21 at 12:36 PMmarketbeat.com - February 21 at 12:14 PMIncannex Healthcare: Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessationfinanznachrichten.de - February 16 at 3:35 PMIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessationfinance.yahoo.com - February 16 at 9:54 AMIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessationglobenewswire.com - February 16 at 7:30 AMWe're Keeping An Eye On Incannex Healthcare's (NASDAQ:IXHL) Cash Burn Ratefinance.yahoo.com - February 4 at 9:16 AMIncannex Healthcare begins dosing in Phase 2 clinical trial...proactiveinvestors.com - February 1 at 3:04 PMClarion Clinics Open for Psychedelic-Assisted Treatmentsfinance.yahoo.com - February 1 at 10:03 AMPodcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy Frontiersmsn.com - January 25 at 6:33 PMIncannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritisfinance.yahoo.com - January 24 at 7:50 PMIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commencesfinance.yahoo.com - January 18 at 1:24 PMIncannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apneafinance.yahoo.com - January 17 at 7:48 AMIXHL Incannex Healthcare Inc.seekingalpha.com - January 14 at 3:05 PMShort Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Grows By 107.5%marketbeat.com - January 12 at 11:40 PMIncannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Increase in Short Interestmarketbeat.com - December 28 at 3:58 PMPsyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & Moremsn.com - December 27 at 12:54 PMIncannex Healthcare Stock (NASDAQ:IXHL) Dividends: History, Yield and Datesbenzinga.com - December 24 at 8:35 AMIncannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australiamsn.com - December 23 at 12:14 AM5 Biotech stocks tapping into unmet mental health treatment needs (IXHL)marketbeat.com - December 20 at 9:01 AMmarketbeat.com - December 6 at 10:28 AMIncannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apneafinance.yahoo.com - December 6 at 10:23 AMmarketbeat.com - December 5 at 10:55 AMmarketbeat.com - December 5 at 10:41 AMmarketbeat.com - December 5 at 10:27 AMmarketbeat.com - December 4 at 12:54 PMmarketbeat.com - December 4 at 12:43 PMmarketbeat.com - December 4 at 12:32 PMmarketbeat.com - December 4 at 12:26 PMU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 1.47%msn.com - November 30 at 8:42 PMmarketbeat.com - November 30 at 4:03 PMmarketbeat.com - November 30 at 2:54 PMmarketbeat.com - November 30 at 2:40 PMmarketbeat.com - November 30 at 2:33 PMmarketbeat.com - November 30 at 2:27 PMmarketbeat.com - November 30 at 2:21 PMmarketbeat.com - November 30 at 2:16 PMmarketbeat.com - November 30 at 1:55 PMmarketbeat.com - November 30 at 1:50 PM Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Thousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" IXHL Media Mentions By Week IXHL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IXHL News Sentiment▼0.590.41▲Average Medical News Sentiment IXHL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IXHL Articles This Week▼22▲IXHL Articles Average Week Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CervoMed News Skye Bioscience News Renovaro News Spyre Therapeutics News I-Mab News Regulus Therapeutics News scPharmaceuticals News GlycoMimetics News Relmada Therapeutics News Amylyx Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IXHL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
